Innovation

A French SME offers to biotech and pharma industries services or co-research based on analysis of microtubule cytoskeleton in the field of neurodegeneration   A French biotechnology start-up develops novel solutions to treat neurodegeneration, a process linked with microtubule disorders. It develops compounds to restore microtubule stability in glaucoma and thus secured assets and has become expert in microtubule analysis in various models and pathologies. Its expertise...

Read More

A Spanish university has developed a method for the diagnosis and prevention of colorectal cancer (CRC). Specifically, an accurate, simple, sensitive and efficient method of extraction and analysis of volatile organic compounds for application as a non-invasive screening test of CRC (stool analysis). It can be used in a wide range of patients, eliminating/reducing the number of false positives/negatives. Companies interested in license or technical...

Read More

Asahi Kasei Pharma aims to expand and enrich the lives of people around the world through the research and development of new drugs and pharmaceutical technologies.   To achieve these goals, they have been promoting and strengthening open innovation activities worldwide. These activities include the introduction of cutting-edge technologies, partnership formation, and research collaboration. As described below, they are focused on facilitating the discovery of preclinical lead...

Read More

An Italian research group has developed new therapeutic approaches to neurodegenerative and autoinflammatory pathologies. The research group is interested in finding partners for developing the research targeting neurological diseases. Partners may be pharmaceutical companies, startup or other research groups interested in research collaborations, in technical or research cooperation agreements or joint future developments of a product.   Recent findings have highlighted the important role played by the...

Read More

Partner Opportunity Alert   An Italian biotech company developed a specialized screening platform for drug development. The company is offerings its technological cooperation to possibile partners and commercial agreements with technical assistance.   talian company developed a specialized screening platform for drug development. The device represents a reliable alternative to animal experimentation and offers a solid approach for in vitro personalized testing, allowing a better evaluation of compound’s action...

Read More

Is your business an innovative tech scale-up with international growth ambitions? Are you looking for capital investment, new customers, the networks to help you achieve global success?   Then the Tech Rocketship Awards Europe are for you.   Created by the UK’s Department for International Trade (DIT), the Awards will unearth Europe’s next tech superstars who have a demonstrable fit with the UK market. The Tech Rocketship Awards will provide...

Read More

Partners from different research areas e.g. medicine, medical devices, electrical engineering and manufacturing are sought for joining a network on detection of vital parameters from sweat   A German research institute establishes a network for exchange of knowledge and data regarding the detection of vital parameters from sweat. Sweat analysis is especially interesting for continuous, non-invasive monitoring of biomarkers.  As the field of sweat analysis is highly...

Read More

A well-known French institute will coordinate a European Training Network that would be dedicated to repurpose mammalian (cancer) epigenetic libraries / compounds for anti-microbial therapy. To properly answer this European Commission challenge, an industrial partner is sought. Ideally, the partner will be an SME with expertise in chemistry, drug profiling, pre-clinical testing, and epigenetic analysis.   Description: The French institute specialized in infectious diseases would like to coordinate...

Read More

  A Spanish research centre, has jointly developed with a Israeli university, a family of compounds able to inhibit Semaphorin3A fostering nerve regeneration after injury. These compounds can be useful for treatment of ischemic events such as stroke, glaucoma and other optical nerve and retina insults. Biotech or pharmaceutical companies are sought for license agreement and/or research collaboration to perform preclinical assays.   After a neuronal damage is...

Read More
Twins’ International Multihelix

Curious about how your company can benefit from twinning programs? Looking for more information on pre- and soft landing?   Join the free introduction with speakers from North America, Asia and Europe to learn more about what the international Network called TIM can do for your business and explore the fundamentals of pre-and soft landing. The webinar will also provide support for companies to survive the covid-19 crisis and prepare...

Read More